Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Accolade to Announce Fiscal Second Quarter 2025 Financial Results
-
VERSES and Analog Announce Smart City Initiative in Abu Dhabi
-
SaverOne Announces New Pilot with Malta Public Transport Company
-
Nano Labs Announces First Half of 2024 Financial Results
-
Dickey’s Barbecue Bringing Back Their Pink Big Yellow Cup to Support Breast Cancer Awareness
-
FangDD Announces Effective Date for Its Substitution Listing Plan
-
Lotus Revealed Groundbreaking Concept Car: A Leap into the Future of Automotive Design
-
WillScot and McGrath RentCorp Mutually Agree to Terminate Previously Announced Combination
-
Casella Waste Systems Announces Pricing of Public Offering of 4,500,000 Shares of Class A Common Stock
-
New research finds rise of infostealer malware and digital identity exposure creates the perfect storm for ransomware attacks
-
Brera Holdings Secures Key Wins for Brera Ilch FC in Mongolia and Brera Strumica FC in North Macedonia, Under New Coaches Gorazd Mihajlov and Toshiaki Imai
-
Clarks Partners with Super League to Bring Stranger Things Collaboration to Roblox with Limited-Edition Digital Items
-
Accredited Solutions Reaches Agreement With 100% of Promissory Note Holders for 60-Day Lock-Up and 6-Month Leak-Out on All Conversions
-
Myriad Genetics to Share New Data Highlighting Genetic Testing Advancements at 2024 National Society of Genetic Counselors Annual Conference
-
New Data to be Presented from EFTISARC-NEO Phase II Evaluating Novel Triple Combination including Immutep’s Efti in Soft Tissue Sarcoma
-
Golden Matrix Group Subsidiary Expanse Studios Enters New Market Segment With Launch of First Social Casino Game
-
2025 CPM Trends: Businesses Embrace Predictive Tools to Navigate Uncertainty
-
Tempest Further Strengthens Leadership Team with Appointment of Sheldon Mullins as Vice President, Regulatory Affairs
-
Newly Launched Nonprofit Colorado Paralysis Foundation Receives $20,000 in Sponsorship from the Christopher & Dana Reeve Foundation
-
ScribeAmerica Announces EHR Integrations for Speke AI
-
BiomX to Provide Latest Update on Positive Phase 1b/2a Clinical Trial Data for BX004 at the North American Cystic Fibrosis Conference
-
Orange County Fire Authority tests SensoRyAI Ultra-Early Wildfire Detection Platform
-
Redwood Logistics Celebrates Christy Ament and Sally Steel-Ginis as 2024 Women in Supply Chain Award Recipients
-
Janover Launches Janover Engage on its Groundbreaker Platform, Connecting Real Estate Syndicators to an Investor Pool Exceeding $1 Billion
-
Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug
-
Holding(s) in Company
-
Technip Energies appoints Benjamin Lechuga as new Chief Strategy & Sustainability Officer
-
Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug
-
Extraordinary General Assembly RIAS A/S
-
BriaCell Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer Patients
-
New National Cybersecurity Campaign Promotes the Power of a 9-Second Pause
-
Alaska Energy Metals Partners with Colorado School of Mines and Virginia Polytechnic Institute to Study Carbon Sequestration Potential of the Eureka Nickel Deposit, Alaska, USA
-
Electra and Three Fires Group Announce Aki Battery Recycling Joint Venture
-
Silicon-Based Anode Batteries Achieve 3,734 mAh with 96% Capacity Retention after 200 Cycles, Surpassing Commercial Alternatives by 66%
-
StorageVault Completes Purchase for $71,500,000
-
Opthea Announces Completion of Drug Substance PPQ Campaign Validating Manufacturing Process of Sozinibercept
-
Plus Therapeutics Showcases New Interim ReSPECT-GBM Phase 2 Trial Data at the 2024 Congress of Neurological Surgeons Annual Meeting
-
Orion Group Holdings to Participate in D.A. Davidson’s 23rd Annual Diversified Industrials & Services Conference
-
Vanqua Bio to Participate in Upcoming Scientific Conferences
-
Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
-
Orion Group Holdings to Participate in D.A. Davidson’s 23rd Annual Diversified Industrials & Services Conference
-
Venus Concept Announces Australian Regulatory Approval for Venus Bliss MAX
-
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Safety Pharmacology Society Annual Meeting
-
Intouch Insight Confirms: DoorDash Leads, Restaurants Beat Out Convenience Stores, and Order Batching Hurts Customer Experience in Third-Party Delivery.
-
RefMed Announces Mike Lundberg as New Chief Client Officer
-
New BRIUMVI® (ublituximab-xiiy) Data from the ENHANCE Phase 3b Study Show Rapid 30-Minute Infusions are Well Tolerated in Patients with Relapsing Forms of Multiple Sclerosis
-
Introducing OTORIO Titan, The Next Evolution in IoT-OT-CPS Security
-
Goliath Upsizes Non-Brokered Placement From $14,725,000 To $15,725,500 As Strategic Investor Mr. Larry Childress Increases Share Purchase From 1,000,000 To 1,400,000
-
Registration Now Open for the Keiretsu Forum 2024 Investor Capital Expo in Philadelphia
-
A-GAME Announces Mario Magro as its Chief Marketing Officer
